<DOC>
	<DOCNO>NCT02464501</DOCNO>
	<brief_summary>The purpose study assess safety efficacy paclitaxel administration use occlusion-perfusion catheter ( OPC ) prevention restenosis infrainguinal de novo restenotic femoropopliteal stenosis occlusion .</brief_summary>
	<brief_title>The OPC Optimal Delivery Paclitaxel Prevention Endovascular Restenosis - Above Knee</brief_title>
	<detailed_description>The purpose COPPER-A study demonstrate safety efficacy paclitaxel administration use OPC prevention restenosis infrainguinal de novo restenotic femoropopliteal lesion . Subjects treat endovascular intervention select treat physician reference vessel range 4mm 7mm diameter . Following achievement optimal interventional result ( less thirty ( 30 ) percent residual stenosis without stenting ) OPC place interventional treatment area paclitaxel deliver treat segment . Data collect assess acute safety , long-term safety durability demonstrate safety efficacy paclitaxel deliver ACT , Inc. OPC device .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>General Willing able provide inform consent comply study requirement ; Candidate peripheral vascular femoropopliteal percutaneous intervention ; Must ≥ 18 year age ; Rutherford category 2 , 3 , 4 , 5 ; Willing able tolerate dual Antiplatelet therapy ( APT ) minimum one ( 1 ) month ; Labwork within acceptable limit accord standard care ; INR &lt; 2.0 warfarin warfarin ; Minimum Sheath size use interventional procedure 7F . General Life expectancy &lt; three ( 3 ) year ; Planned amputation prior procedure ; Pregnancy nursing ( pregnancy test require woman childbearing capability ≤ 7 day prior index procedure ) ; Previous intervention target lesion stent , drug elute balloon , drug delivery catheter ; Any treatment target vessel drug elute balloon ; Known allergy paclitaxel ; Known hypersensitivity drug manufacture Cremophor® EL ( polyoxyethylated castor oil ; e.g . Drugs contain polyoxyethylated castor oil drug miconazole , cyclosporine injection , nelfinavir mesylate , saperconazole , tacrolimus , xenaderm ointment ) ; 12 Known allergy anticoagulant ; Known TRUE acetylsalicylic acid ( ASA ) allergy ; Use glycoprotein ( GP ) IIb/IIIa inhibitor procedure visit within 30 day follow index procedure ; Target lesion treat cryoplasty balloon time index procedure ; Hemorrhagic stroke within six ( 6 ) month ; Renal failure chronic kidney disease GFR ≤30 ml/min MDRD GFR ≤30 ml/min per 1.73 m2 ( serum creatinine ≥2.5 mg/L within 30 day index procedure treat dialysis ) unless CO2 use visualization ; Prior vascular surgery index limb ; Current enrollment another investigational device drug study ; After obtain informed consent , point introduction OPC , investigator determines study subject appropriate study . Angiographic Reference vessel diameter ( RVD ) ≥ 4mm ≤ 7mm ; Single multiple lesion SFA and/or popliteal artery ; For single lesion treatment , minimum lesion length ≥ 20mm ; Minimum one patent infrapopliteal vessel ; Preintervention percent DS ≥ 70 % . Angiographic Flow limit dissection necessitate stent placement prior OPC use ; Post PTA residual stenosis ≥ 30 % visualized treating physician ; Perforation require covered stent ; Lesion occlusion location extend distally beyond P2 region popliteal artery ; Target lesion within fractured stent ; Target lesion within stent restenosed two ( 2 ) time ; Significant ( ≥ 50 % DS ) inflow lesion occlusion leave untreated ipsilateral Iliac , SFA , popliteal artery proximal target lesion ; A lesion treat distal target lesion result compromise inline flow distal target lesion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PAD</keyword>
	<keyword>COPPER-A</keyword>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>OPC</keyword>
	<keyword>Occlusion Perfusion Catheter</keyword>
	<keyword>Paclitaxel</keyword>
</DOC>